EUROPEAN BIOTECH ACQUISITI-A (EBAC)

KYG3167F1028 - Common Stock

11.19  -0.52 (-4.44%)

After market: 10.87 -0.32 (-2.86%)

News Image
a year ago - Seeking Alpha

SPAC European Biotech shareholders appprove merger with Oculis (NASDAQ:EBAC)

Dutch SPAC European Biotech Acquisition Corp. (EBAC) shareholders have approved a merger with Swiss biotech Oculis, a deal that valued the combined company at around $220M. Read more here.

News Image